SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0000891293-13-000035
Filing Date
2013-08-08
Accepted
2013-08-08 18:34:01
Documents
1
Period of Report
2013-08-06
Filing Date Changed
2013-08-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4461
  Complete submission text file 0000891293-13-000035.txt   5850
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O SPACELABS MEDICAL INC 15220 NE 40TH ST REDMOND WA 98053
Business Address
NUDELMAN PHILLIP M PHD (Reporting) CIK: 0001041084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 131023545